Episode 31 – Tirzepatide and Bariatric Surgery on Cardiovascular Health

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Mike and John do a Rapid Fire session to discuss two recent papers exploring the cardiovascular benefits of a novel diabetes medication and bariatric surgery. Two papers, here we go!

  1. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis (0:00 – 9:04).
  2. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomized, open-label, parallel-group, multicentre, phase 3 trial (9:04 – 14:52).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more